BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10229801)

  • 1. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
    Constant S; Schweitzer N; West J; Ranney P; Bottomly K
    J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
    Lenschow DJ; Sperling AI; Cooke MP; Freeman G; Rhee L; Decker DC; Gray G; Nadler LM; Goodnow CC; Bluestone JA
    J Immunol; 1994 Sep; 153(5):1990-7. PubMed ID: 7519638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I; Weinberg AD; Lemon M; Croft M
    J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
    Jones KW; Hackett CJ
    Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7/CD28-dependent and -independent induction of CD40 ligand expression.
    Ding L; Green JM; Thompson CB; Shevach EM
    J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
    Lahvis GP; Cerny J
    J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
    Rodríguez-Pinto D; Moreno J
    Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE; Stavnezer J; Kikutani H; Parker DC
    J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cell priming by B lymphocytes is CD4 help dependent.
    Castiglioni P; Gerloni M; Cortez-Gonzalez X; Zanetti M
    Eur J Immunol; 2005 May; 35(5):1360-70. PubMed ID: 15816014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help.
    Macaulay AE; DeKruyff RH; Umetsu DT
    J Immunol; 1998 Feb; 160(4):1694-700. PubMed ID: 9469426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands.
    Khoruts A; Osness RE; Jenkins MK
    Eur J Immunol; 2004 Apr; 34(4):1085-90. PubMed ID: 15048719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.
    Yellin MJ; Sinning J; Covey LR; Sherman W; Lee JJ; Glickman-Nir E; Sippel KC; Rogers J; Cleary AM; Parker M
    J Immunol; 1994 Jul; 153(2):666-74. PubMed ID: 7517421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.